Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
Clinical trial NCT03610464 · COMPLETED
Trial details
- NCT number
- NCT03610464
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2018-05-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.